Q2B Validation of Analytical Procedures: Methodology
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
May 19, 1997
April 14, 2020
582c54c8-1b4b-41ac-9986-b492b25f4794
Related Documents
S1B Testing for Carcinogenicity of Pharmaceuticals
Guidance DocumentFebruary 23, 1998Center for Drug Evaluation and Research
Q1B Photostability Testing of New Drug Substances and Products
Guidance DocumentMarch 7, 1996Center for Drug Evaluation and Research
S6 Preclinical Safety Evaluation of Biotechnology-Derived Pharmaceuticals
Guidance DocumentNovember 18, 1997Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Stay ahead of FDA enforcement
New KeyPedia insights, webinars, and regulatory analysis — straight to your inbox. Unsubscribe anytime.